• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Del Global settles class action

Article

A U.S. District Court in New York has approved the terms of a settlement between Del Global Technologies and its shareholders, dismissing all claims against Del and other defendants without any findings of liability or wrongdoing

A U.S. District Court in New York has approved the terms of a settlement between Del Global Technologies and its shareholders, dismissing all claims against Del and other defendants without any findings of liability or wrongdoing by any party, according to the company. Under the court-approved agreement, members of the class action will receive $2 million in cash and $2 million of subordinated promissory notes due in five years bearing interest at 6% per annum. Class action litigants will also receive 2.5 million shares of Del common stock with warrants to purchase one million shares of Del's common stock exercisable at $2 per share, expiring six years from the date of execution. Del Global develops and markets stationary and portable x-ray systems, as well as radio-frequency, mammography, and dental imaging systems. The company also makes high-voltage power conversion subsystems for medical and industrial applications.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.